Talk:Ativisha: Difference between revisions
Dridhabala (talk | contribs) No edit summary |
Dridhabala (talk | contribs) No edit summary |
||
| Line 205: | Line 205: | ||
== Major Phytoconstituents == | == Major Phytoconstituents == | ||
The pharmacological properties of ''Aconitum heterophyllum'' are primarily attributed to its diterpenoid alkaloids, which are concentrated in the root tubers:<ref name="Mathew2023" /> | The pharmacological properties of ''Aconitum heterophyllum'' are primarily attributed to its diterpenoid alkaloids, which are concentrated in the root tubers:<ref name="Mathew2023" /> | ||
* '''Diterpenoid Alkaloids:''' Atisine,<ref name="Malhotra2014" /><ref name="Jowett1896" /> atidine,<ref name="Jowett1896" /> heteratisine and benzoylheteratisine, | * '''Diterpenoid Alkaloids:''' Atisine,<ref name="Malhotra2014" /><ref name="Jowett1896" /> atidine,<ref name="Jowett1896" /> heteratisine and benzoylheteratisine, and aconitine (used as the HPLC marker compound for standardisation).<ref name="Prasad2014" /> Heterophylline, heterophylloidine, fischimine and aconine derivatives <sup>[citation needed]</sup> | ||
* '''Lactones & Flavonoids:''' Bitter principles and phenolic compounds contributing to digestive and anti-inflammatory actions | * '''Lactones & Flavonoids:''' Bitter principles and phenolic compounds contributing to digestive and anti-inflammatory actions | ||
| Line 260: | Line 260: | ||
<ref name="Wani2022">Wani TA, Kaloo ZA, Dangroo NA. ''Aconitum heterophyllum'' Wall. ex Royle: a critically endangered medicinal herb with rich potential for use in medicine. ''J Integr Med''. 2022;20(2):104–113. [https://doi.org/10.1016/j.joim.2021.12.004 doi:10.1016/j.joim.2021.12.004]</ref> | <ref name="Wani2022">Wani TA, Kaloo ZA, Dangroo NA. ''Aconitum heterophyllum'' Wall. ex Royle: a critically endangered medicinal herb with rich potential for use in medicine. ''J Integr Med''. 2022;20(2):104–113. [https://doi.org/10.1016/j.joim.2021.12.004 doi:10.1016/j.joim.2021.12.004]</ref> | ||
<ref name="Malhotra2014">Malhotra N, Kumar V, Sood H, Singh TR, Chauhan RS. Multiple genes of mevalonate and non-mevalonate pathways contribute to high aconites content in an endangered medicinal herb, ''Aconitum heterophyllum'' Wall. ''Phytochemistry''. 2014;108:26–34. [https://doi.org/10.1016/j.phytochem.2014.08.025 doi:10.1016/j.phytochem.2014.08.025]</ref> | <ref name="Malhotra2014">Malhotra N, Kumar V, Sood H, Singh TR, Chauhan RS. Multiple genes of mevalonate and non-mevalonate pathways contribute to high aconites content in an endangered medicinal herb, ''Aconitum heterophyllum'' Wall. ''Phytochemistry''. 2014;108:26–34. [https://doi.org/10.1016/j.phytochem.2014.08.025 doi:10.1016/j.phytochem.2014.08.025]</ref> | ||
<ref name="Jowett1896">Jowett HAD. Contributions to our knowledge of the aconite alkaloids. Part XIII. On atisine, the alkaloid of ''Aconitum heterophyllum''. ''J Chem Soc Trans''. 1896;69:1518–1526. [https://doi.org/10.1039/CT8966901518 doi:10.1039/CT8966901518]</ref> | <ref name="Jowett1896">Jowett HAD. Contributions to our knowledge of the aconite alkaloids. Part XIII. On atisine, the alkaloid of ''Aconitum heterophyllum''. ''J Chem Soc Trans''. 1896;69:1518–1526. [https://doi.org/10.1039/CT8966901518 doi:10.1039/CT8966901518]</ref> | ||
}} | }} | ||